In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Inverness Medical Innovations buys Abbott's rapid Dx line

Executive Summary

Concurrent with the settlement of disputes between the two companies, Inverness Medical Innovations (women's health diagnostics, vitamins, and nutritional supplements) has acquired several rapid diagnostic product lines and related IP from Abbott Laboratories for $92.6mm in cash and stock.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register